HeartBeam (BEAT) to Post Earnings on Thursday

HeartBeam (NASDAQ:BEAT) is anticipated to issue its Q2 2026 results after the market closes on Thursday, August 13th. Analysts expect the company to announce earnings of ($0.10) per share and revenue of $0.1470 million for the quarter. Investors may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 13, 2026 at 4:30 PM ET.

HeartBeam (NASDAQ:BEAT) last announced its quarterly earnings results on Wednesday, May 13th. The medical research company reported ($0.12) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.02. On average, analysts expect HeartBeam to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

HeartBeam Trading Up 7.0%

NASDAQ BEAT opened at $0.59 on Wednesday. The company has a fifty day simple moving average of $0.65 and a 200 day simple moving average of $1.00. HeartBeam has a 12-month low of $0.48 and a 12-month high of $4.00. The company has a market cap of $32.59 million, a P/E ratio of -1.05 and a beta of -0.78.

Institutional Trading of HeartBeam

A number of institutional investors and hedge funds have recently modified their holdings of BEAT. CIBC Private Wealth Group LLC purchased a new position in HeartBeam in the fourth quarter valued at about $26,000. Geode Capital Management LLC increased its stake in shares of HeartBeam by 4.1% during the 4th quarter. Geode Capital Management LLC now owns 305,740 shares of the medical research company’s stock worth $734,000 after purchasing an additional 12,142 shares during the last quarter. Raymond James Financial Inc. raised its holdings in shares of HeartBeam by 102.2% in the 2nd quarter. Raymond James Financial Inc. now owns 28,178 shares of the medical research company’s stock worth $35,000 after purchasing an additional 14,242 shares during the period. Jane Street Group LLC bought a new stake in shares of HeartBeam in the 4th quarter worth approximately $55,000. Finally, Virtu Financial LLC purchased a new position in HeartBeam in the fourth quarter valued at approximately $70,000. 7.77% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. HC Wainwright dropped their price objective on shares of HeartBeam from $5.50 to $2.50 and set a “buy” rating on the stock in a research note on Friday, May 22nd. Wall Street Zen raised shares of HeartBeam from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. Maxim Group initiated coverage on shares of HeartBeam in a report on Tuesday, July 14th. They issued a “buy” rating and a $2.00 target price on the stock. D. Boral Capital cut shares of HeartBeam from a “buy” rating to a “hold” rating in a research report on Monday, April 20th. Finally, Benchmark cut their price target on HeartBeam from $8.00 to $5.00 and set a “speculative buy” rating for the company in a research note on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, HeartBeam presently has a consensus rating of “Moderate Buy” and an average price target of $4.00.

About HeartBeam

BioTelemetry, Inc, a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors.